Amibegron

Drug Profile

Amibegron

Alternative Names: SR 58611; SR 58611A

Latest Information Update: 12 Aug 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator sanofi-aventis
  • Class Antidepressants; Carboxylic acids; Naphthalenes; Small molecules
  • Mechanism of Action Beta 3 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Generalised anxiety disorder; Irritable bowel syndrome; Major depressive disorder; Obesity

Most Recent Events

  • 31 Jul 2008 Discontinued - Phase-III for Depression in Argentina (unspecified route)
  • 31 Jul 2008 Discontinued - Phase-III for Depression in Asia (unspecified route)
  • 31 Jul 2008 Discontinued - Phase-III for Depression in Croatia (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top